This is an archived page. Images and links on this page may not work. Please visit the main page for the latest updates.

 
 
 
Read my book, TEACHING BEAUTY IN DeLILLO, WOOLF, AND MERRILL (Palgrave Macmillan; forthcoming), co-authored with Jennifer Green-Lewis. VISIT MY BRANCH CAMPUS AT INSIDE HIGHER ED





UD is...
"Salty." (Scott McLemee)
"Unvarnished." (Phi Beta Cons)
"Splendidly splenetic." (Culture Industry)
"Except for University Diaries, most academic blogs are tedious."
(Rate Your Students)
"I think of Soltan as the Maureen Dowd of the blogosphere,
except that Maureen Dowd is kind of a wrecking ball of a writer,
and Soltan isn't. For the life of me, I can't figure out her
politics, but she's pretty fabulous, so who gives a damn?"
(Tenured Radical)

Saturday, September 02, 2006

UD's Academic Conflict of Interest Tickertape

They are endemic. Only the biggies make it to the press. Since they are happening all the time, all around us, UD rarely mentions them. She asks you to imagine a tickertape running through University Diaries, which UD sometimes stops in order to highlight a particularly outrageous case. Like this one.


The editor of a U.S. medical journal has resigned in the midst of recent news that he failed to disclose financial ties to industry.

According to a report in the Wall Street Journal Monday, Charles Nemeroff, the editor of the medical journal Neuropsychopharmacology, stepped down amid reports he had failed to disclose his financial ties to Cyberonics, the maker of an anti-depression device for which he had written a favorable article. The article in question also failed to disclose that seven other authors of the article served as consultants to the company, while an eighth author was employed by Cyberonics, the newspaper reported.

The article, published in the journal last month, described Cyberonics' product -- a device implanted in the patient's chest to deliver electrical impulses to the vagus nerve as a treatment for depression -- as "a promising and well-tolerated intervention," WSJ said.

The medical journal has since published a correction to the article.


Note that he was the editor of the journal.

Nemeroff's been doing this sort of thing for years, a quick Google search reveals. No one seems to care. I'm sure his position at Emory University remains secure.